Studies have found that programmed cell death-1 (PD-1) on tumor-infiltrating lymphocytes (TILS) can be combined with the programmed death ligand-1 (PD-L1) on tumor cells and then inhibits T cell proliferation and activation, thus inducing immune escape of tumor cells [3–6]. Here, CD274 is linked to neoplasm.